$AETR Balance Sheet | Understand Stock

$AETR

$2.22 -$0.02 (0.89%) Close

$AETR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q4 FY2013 As of Dec 31, 2013	Q4 FY2012 As of Dec 31, 2012
Assets
Current assets:
Short-term investments
Cash and cash equivalents from continuing operations, end of year (including restricted cash)
Accounts receivable (note 6)
Inventories (note 7)
Prepaid expenses
Current portion of deferred income tax assets (note 19(b))
Current assets held for sale (note 6)
Assets held for sale (note 5)
Total current assets

Long-term investments (note 8)
Property, plant and equipment (note 9)
Operating lease right-of-use assets
Intangible assets (note 10)
Deferred income tax assets (note 19(b))
Goodwill (note 11)
Other long-term assets (note 10)
Long-term assets held for sale (note 5)
Total assets
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable and accrued liabilities (note 11)
Restructuring obligations (note 14)
Deferred revenue
Current portion of deferred income tax liabilities (note 19(b))
Current portion of operating lease liabilities
Short-term debt (note 15)
Current portion of long-term debt (note 12)
Current portion of long-term royalty payable (note 16)
Current portion of warranty liability
Liabilities held for sale (note 6)
Current liabilities held for sale (note 5)
Total current liabilities

Restructuring obligation (note 14)
Deferred revenue
Long-term operating lease liabilities
Long-term debt (note 12)
Long-term royalty payable (note 16)
Warranty liability
Deferred income tax liabilities (note 19(b))
Other long-term liabilities
Long-term liabilities held for sale (note 5)
Total liabilities
Shareholders’ equity:
Share capital (note 13):
Unlimited common and preferred shares, no par value 17,282,934 (2024 - 17,174,502) common shares issued and outstanding
Other equity instruments

Other equity instruments
Additional paid-in-capital
Accumulated deficit
Accumulated other comprehensive loss
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Total shareholders' equity

Total liabilities and shareholders' equity

Comments